# S&B Pharma LLC – FDA Inspection, Mar 16, 2018

Source: https://www.keypedia.com/records/fda_inspections/sb-pharma-llc/9d542333-9374-409a-93d6-381f4b1aa795
Source feed: FDA_Inspections

> FDA inspection 1047928 of S&B Pharma LLC, March 16, 2018. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 9 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1047928
- Company Name: S&B Pharma LLC
- Inspection Date: 2018-03-16
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1172319 - 2022-06-17
- FDA Inspection 1121238 - 2020-02-06
- [FDA Inspection 1078320 - 2019-02-05](https://www.keypedia.com/records/fda_inspections/sb-pharma-llc/636a1ff3-2f57-4421-b804-895b6916ba04)
- FDA Inspection 1031001 - 2017-10-27
- FDA Inspection 915801 - 2015-02-26

## Related Officers

- [Company Rep](https://www.keypedia.com/people/karen-m-montgomery/ee91b1bb-8d51-4fdc-bee5-949441136e59)
- Issuing Officer

Company: https://www.keypedia.com/companies/sb-pharma-llc/232b2ea9-4ea7-41e2-aed7-7b885ca80003

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c